In this issue:
SVR post-LT induces fibrosis regression
HCV transmission from HCV Ab+/NAT– donors
miRNA signatures for viral persistence & hepatocellular injury?
In vitro analysis of vesotolimod antiviral effects
In vivo antiviral response to vesotolimod
Adding vesotolimod to immune modulation strategies
Resistance analysis of sofosbuvir/velpatasvir treatment outcomes
DAAT survival benefit in chronic HCV patients on haemodialysis
HBV and the innate immune system
HBV is invisible to pattern recognition receptors
Please login below to download this issue (PDF)